Brief: Genovis To Own 25% Of Sequrna Following Strategic Investment

Genovis AB

04/07/2024 13:51

July 4 (Reuters) - Genovis AB  GENOb.ST :
    * COMPLETES A STRATEGIC INVESTMENT IN SEQURNA, A DEVELOPER
OF
NEXT-GENERATION RNASE INHIBITORS
    * FOLLOWING INVESTMENT, GENOVIS WILL OWN 25 PERCENT OF
SEQURNA
    * PARTIES HAVE AGREED TO A CALL OPTION WITH AN END DATE ON
30 JUNE
2027, PROVIDING GENOVIS RIGHT TO ACQUIRE ALL SHARES OF SEQURNA

Source text for Eikon:  ID:nWkr1mS5TC 
Further company coverage:  GENOb.ST 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))